IT1244697B - Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale - Google Patents
Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausaleInfo
- Publication number
- IT1244697B IT1244697B ITMI910253A ITMI910253A IT1244697B IT 1244697 B IT1244697 B IT 1244697B IT MI910253 A ITMI910253 A IT MI910253A IT MI910253 A ITMI910253 A IT MI910253A IT 1244697 B IT1244697 B IT 1244697B
- Authority
- IT
- Italy
- Prior art keywords
- prevention
- treatment
- ipriflavone
- post
- pharmaceutical association
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Abstract
Associazioni estemporanee e fisse di ipriflavone ed estrogeni naturali coniugati nella prevenzione e nel trattamento dell'osteoporosi post-menopausale presentano sorprendenti vantaggi.Si dimostra infatti che associando dosi terapeutiche di ipriflavone, agente terapeutico per l'osteoporosi, a dosi sub-attive di estrogeni naturali coniugati si incrementa l'efficacia dell'ipriflavone nei confronti della demineralizzazione ossea, assicurando contemporaneamente il controllo da parte degli estrogeni della sintomatologia tipica del climaterio.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI910253A IT1244697B (it) | 1991-02-01 | 1991-02-01 | Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale |
IE021992A IE920219A1 (en) | 1991-02-01 | 1992-01-24 | Pharmaceutical combination for the prevention and treatment¹of postmenopausal osteoporosis |
NZ241418A NZ241418A (en) | 1991-02-01 | 1992-01-27 | Synergistic compositions comprising ipriflavone and at least one oestrogen |
HU9302183A HUT64848A (en) | 1991-02-01 | 1992-01-28 | Medical preparatives for preventing and treating osteoporises after menopausa |
PCT/EP1992/000174 WO1992013538A1 (en) | 1991-02-01 | 1992-01-28 | Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis |
AU11884/92A AU1188492A (en) | 1991-02-01 | 1992-01-28 | Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis |
EP92903484A EP0569415A1 (en) | 1991-02-01 | 1992-01-28 | Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis |
CA002101547A CA2101547A1 (en) | 1991-02-01 | 1992-01-28 | Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis |
ZA92661A ZA92661B (en) | 1991-02-01 | 1992-01-30 | Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI910253A IT1244697B (it) | 1991-02-01 | 1991-02-01 | Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI910253A0 ITMI910253A0 (it) | 1991-02-01 |
ITMI910253A1 ITMI910253A1 (it) | 1992-08-01 |
IT1244697B true IT1244697B (it) | 1994-08-08 |
Family
ID=11358374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI910253A IT1244697B (it) | 1991-02-01 | 1991-02-01 | Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0569415A1 (it) |
AU (1) | AU1188492A (it) |
CA (1) | CA2101547A1 (it) |
HU (1) | HUT64848A (it) |
IE (1) | IE920219A1 (it) |
IT (1) | IT1244697B (it) |
NZ (1) | NZ241418A (it) |
WO (1) | WO1992013538A1 (it) |
ZA (1) | ZA92661B (it) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994023716A1 (en) * | 1993-04-16 | 1994-10-27 | Tufts University School Of Medicine | Method for treatment of menopausal and premenstrual symptoms |
HU212932B (en) * | 1993-08-02 | 1996-12-30 | Chinoin Gyogyszer Es Vegyeszet | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
US5554601A (en) * | 1993-11-05 | 1996-09-10 | University Of Florida | Methods for neuroprotection |
US6319914B1 (en) | 1993-11-05 | 2001-11-20 | Apollo Biopharmaceuticals, Inc. | Cytoprotective effect of polycyclic phenolic compounds |
US5506211A (en) * | 1994-05-09 | 1996-04-09 | The Uab Research Foundation | Genistein for use in inhibiting osteroclasts |
US6326365B1 (en) | 1999-07-20 | 2001-12-04 | Apollo Biopharmaceutics, Inc. | Methods of prevention and treatment of ischemic damage |
US6339078B1 (en) | 1999-07-20 | 2002-01-15 | University Of Florida Research Foundation, Inc. | Methods of prevention and treatment of ischemic damage |
JP2004524354A (ja) * | 2001-03-16 | 2004-08-12 | ワイス | エストロゲン補充療法 |
WO2008051586A2 (en) | 2006-10-24 | 2008-05-02 | Krempin David W | Anti-resorptive and bone building dietary supplements and methods of use |
-
1991
- 1991-02-01 IT ITMI910253A patent/IT1244697B/it active IP Right Grant
-
1992
- 1992-01-24 IE IE021992A patent/IE920219A1/en unknown
- 1992-01-27 NZ NZ241418A patent/NZ241418A/xx unknown
- 1992-01-28 WO PCT/EP1992/000174 patent/WO1992013538A1/en not_active Application Discontinuation
- 1992-01-28 HU HU9302183A patent/HUT64848A/hu unknown
- 1992-01-28 AU AU11884/92A patent/AU1188492A/en not_active Abandoned
- 1992-01-28 CA CA002101547A patent/CA2101547A1/en not_active Abandoned
- 1992-01-28 EP EP92903484A patent/EP0569415A1/en not_active Ceased
- 1992-01-30 ZA ZA92661A patent/ZA92661B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ITMI910253A0 (it) | 1991-02-01 |
ZA92661B (en) | 1992-10-28 |
HUT64848A (en) | 1994-03-28 |
WO1992013538A1 (en) | 1992-08-20 |
AU1188492A (en) | 1992-09-07 |
ITMI910253A1 (it) | 1992-08-01 |
NZ241418A (en) | 1993-03-26 |
HU9302183D0 (en) | 1993-10-28 |
EP0569415A1 (en) | 1993-11-18 |
CA2101547A1 (en) | 1992-08-02 |
IE920219A1 (en) | 1992-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105276T1 (el) | Τριφασικο στοματικο αντισυλληπτικο | |
NZ234051A (en) | Treating post-menopausal disorders using an estrogenic compound mixed with a compound having progestational activity | |
AR031563A1 (es) | Una composicion farmaceutica para emplear en el tratamiento de trastornos menopausicos o posmenopausicos de estrogenos y acetato de medroxiprogesterona, una unidad de dosificacion farmaceutica y uso de una combinacion de estrogenos conjugados y acetato de medroxiprogesterona para la manufactura de u | |
KR960704553A (ko) | 적어도 하나의 프로게스토겐과 적어도 하나의 에스트로겐을 함유하는 대용요법용 제제(preparation for substitution therapy containing at least one progestogen and at least one estrogen) | |
CY2599B2 (en) | Benzothiophene formulations of a specific dosage | |
CA2221753A1 (en) | Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast | |
IT1244697B (it) | Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale | |
ES2087237T3 (es) | Progestogeno como unico contraceptivo. | |
ES2173868T3 (es) | Utilizacion de relaxina para la fabricacion de un medicamento destinado al tratamiento de enfermedades cardiovasculares. | |
EE05259B1 (et) | Antiprogestiinide kasutamine hormoons?ltuvate haiguste proflaktikaks ja raviks | |
ES2135342A1 (es) | Procedimiento para prevenir el cancer de mama. | |
YU18099A (sh) | Hormonalni preparat koji sadrži jedinjenje estrogena i progestativno jedinjenje | |
HUP9900612A2 (hu) | Új hormonális gyógyászati készítmények, valamint a készítmények alkalmazása ösztrogénpótlásra | |
CY1108648T1 (el) | Αναστολεας της αρωματασης σε μια δοση για την θεραπευτικη αντιμετωπιση της υπογόνιμοτήτας | |
DE69430356T2 (de) | Karzinostatisches Mittel für Hormontherapie, das Dienogest als wirksamer Bestandteil enthält | |
UA28644A (uk) | Спосіб лікування первинної аменореї центрального генезу у дівчат-підлітків | |
IT1243978B (it) | Farmaco per uso umano, ad azione contraccettiva ed oncostatica preventiva, nei tumori del seno, dell'utero e nel melanoma. | |
YU30103A (sh) | Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |